primary myelofibrosis
Background: This report aims to describe the results of Ruxolitinib and the other therapies for patients with primary myelofibrosis (PMF) in Blood Transfusion Hematology Hospital (BTH).
Background : This report aims to describe the results of Ruxolitinib and the other therapies for patients with primary myelofibrosis ( PMF ) in Blood Transfusion Hematology Hospital ( BTH ) .